Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis

Cancer Research

Volumn 72, Issue 7, 2012, Pages 1784-1794

  Endo, Motoyoshi ^a   Nakano, Masahiro ^a   Kadomatsu, Tsuyoshi ^a   Fukuhara, Shigetomo ^b   Kuroda, Hiroaki ^c   Mikami, Shuji ^c   Hato, Tai ^c,d   Aoi, Jun ^a   Horiguchi, Haruki ^a   Miyata, Keishi ^a   Odagiri, Haruki ^a   Masuda, Tetsuro ^a   Harada, Masahiko ^d   Horio, Hirotoshi ^d   Hishima, Tsunekazu ^d   Nomori, Hiroaki ^c   Ito, Takaaki ^a   Yamamoto, Yutaka ^a   Minami, Takashi ^e   Okada, Seiji ^a   Takahashi, Takashi ^f   Mochizuki, Naoki ^b   Iwase, Hirotaka ^a   Oike, Yuichi ^a   more..

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 2; PROTEIN C JUN; RAC PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANGPTL2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CELL MOTILITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOPOIETINS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; NFATC TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-JUN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859377402     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3878     Document Type: Article

References (36)

1. Boyle P, Levin B. World Cancer Report 2008. Lyon, France: IARC Press; 2008.
2. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008;359:2814-23.
3. Christofori G. New signals from the invasive front. Nature 2006;441: 444-50. (Pubitemid 44050139)
4. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
5. Aoi J, Endo M, Kadomatsu T, Miyata K, Nakano M, Horiguchi H, et al. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res 2011;71:7502-12.
6. Mancini M, Toker A. NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 2009;9:810-20.
7. Muller MR, Rao A. NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 2010;10:645-56.
8. Flockhart RJ, Armstrong JL, Reynolds NJ, Lovat PE. NFAT signalling is a novel target of oncogenicBRAFin metastatic melanoma. Br J Cancer 2009;101:1448-55.
9. Koenig A, Linhart T, Schlengemann K, Reutlinger K, Wegele J, Adler G, et al. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology 2010;138:1189-99 e1-2.
10. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005;20:539-50. (Pubitemid 41668639)
11. Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, et al. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. J Biol Chem 2005;280:43188-97. (Pubitemid 43049285)
12. Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, et al. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 2010; 176:2309-19.
13. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009;10:178-88.
14. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008;10:513-26. (Pubitemid 351627371)
15. Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T, et al. Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 2000; 60:2535-40. (Pubitemid 30262449)
16. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 2002;4:540-4. (Pubitemid 34752442)
17. Yiu GK, Toker A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 2006;281: 12210-7. (Pubitemid 43855303)
18. Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001;20:2438-52.
19. van Dam H, Castellazzi M. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 2001;20:2453-64.
20. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 1998;392:42-8. (Pubitemid 28150581)
21. Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001;20:2476-89. (Pubitemid 32531304)
22. Ramirez-Carrozzi V, Kerppola T. Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1. Mol Cell Biol 2003;23:1737-49.
23. Szabo E, Riffe ME, Steinberg SM, Birrer MJ, Linnoila RI. Altered cJUN expression: an early event in human lung carcinogenesis. Cancer Res 1996;56:305-15. (Pubitemid 26026359)
24. Shimizu Y, Kinoshita I, Kikuchi J, Yamazaki K, Nishimura M, Birrer MJ, et al. Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. Br J Cancer 2008; 98:915-22. (Pubitemid 351341616)
25. Okada S, Harada H, Ito T, Saito T, Suzu S. Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/ Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells. Int J Hematol 2008;88:476-82.
26. Waterman-Storer CM, Worthylake RA, Liu BP, Burridge K, Salmon ED. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat Cell Biol 1999;1:45-50. (Pubitemid 129495009)
27. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009;4:e6146.
28. Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 2010;10: 65-76.
29. Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V. The role of ATF-2 in oncogenesis. Bioessays 2008;30: 314-27. (Pubitemid 351482329)
30. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 2007;67: 10631-4. (Pubitemid 350145884)
31. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005;115:2656-64. (Pubitemid 41434389)
32. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002;109 Suppl: S67-79. (Pubitemid 34457853)
33. Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009;15:21-34.
34. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, et al. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 2004; 279:50537-54. (Pubitemid 39577872)
35. Minami T, Yano K, Miura M, Kobayashi M, Suehiro J, ReidPC, et al. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J Clin Invest 2009;119:2257-70.
36. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008;135:510-23.